NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Marker Therapeutics Inc (NASDAQ: MRKR)

 
MRKR Technical Analysis
5
As on 9th Jun 2023 MRKR STOCK Price closed @ 2.51 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.44 & Strong Buy for SHORT-TERM with Stoploss of 0.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MRKRSTOCK Price

Open 2.27 Change Price %
High 2.59 1 Day 0.43 20.67
Low 2.15 1 Week 1.23 96.09
Close 2.51 1 Month 1.60 175.82
Volume 558878 1 Year 1.49 146.08
52 Week High 3.12 | 52 Week Low 0.24
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
MRKR
Daily Charts
MRKR
Intraday Charts
Whats New @
Bazaartrend
MRKR
Free Analysis
 
MRKR Important Levels Intraday
RESISTANCE3.36
RESISTANCE3.09
RESISTANCE2.92
RESISTANCE2.75
SUPPORT2.27
SUPPORT2.10
SUPPORT1.93
SUPPORT1.66
 
MRKR Forecast April 2024
4th UP Forecast3.43
3rd UP Forecast3.14
2nd UP Forecast2.95
1st UP Forecast2.77
1st DOWN Forecast2.25
2nd DOWN Forecast2.07
3rd DOWN Forecast1.88
4th DOWN Forecast1.59
 
MRKR Weekly Forecast
4th UP Forecast2.88
3rd UP Forecast2.76
2nd UP Forecast2.69
1st UP Forecast2.61
1st DOWN Forecast2.41
2nd DOWN Forecast2.33
3rd DOWN Forecast2.26
4th DOWN Forecast2.14
 
MRKR Forecast2024
4th UP Forecast8.81
3rd UP Forecast6.79
2nd UP Forecast5.54
1st UP Forecast4.29
1st DOWN Forecast0.73
2nd DOWN Forecast-0.52
3rd DOWN Forecast-1.77
4th DOWN Forecast-3.79
 
 
MRKR Other Details
Segment EQ
Market Capital 122956480.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MRKR Address
MRKR
 
MRKR Latest News
 
Your Comments and Response on Marker Therapeutics Inc
 
MRKR Business Profile
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technology is based on the expansion of non-engineered tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, multiple myeloma, and various solid tumors; and allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia. It is also developing TPIV100/110, which is in Phase II clinical trial for the treatment of breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of breast and ovarian cancers. Marker Therapeutics, Inc. is headquartered in Houston, Texas. Address: Phoenix Tower, Houston, TX, United States, 77027
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service